poisar

Stocks · News reference

Charles River to Acquire Frontage Bioanalysis, DMPK Businesses for $470 Million

Fiscal.ai

Charles River Laboratories International, Inc. has entered into definitive agreements to acquire the bioanalysis and drug metabolism and pharmacokinetics (DMPK) businesses of Frontage Laboratories for $470 million in cash.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading